State of Wisconsin Investment Board Portfolio holdings
AUM
$40.9B
This Quarter Return
+14.65%
1 Year Return
+24.31%
3 Year Return
+99.94%
5 Year Return
+177.86%
10 Year Return
+427.44%
AUM
$35.2B
AUM Growth
+$35.2B
(+15%)
Cap. Flow
+$434M
Cap. Flow
% of AUM
1.23%
Top 10 Holdings %
Top 10 Hldgs %
16.68%
Holding
1,608
New
67
Increased
852
Reduced
590
Closed
71
Top Buys
| 1 |
Walt Disney
DIS
|
$46.4M |
| 2 |
Elevance Health
ELV
|
$44.2M |
| 3 |
Procter & Gamble
PG
|
$41.9M |
| 4 |
PayPal
PYPL
|
$31.6M |
| 5 |
Zillow
ZG
|
$30.2M |
Top Sells
| 1 |
TFCF
Twenty-First Century Fox, Inc. Class B
TFCF
|
$115M |
| 2 |
DocuSign
DOCU
|
$99.2M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$75.3M |
| 4 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
$73M |
| 5 |
Bank of America
BAC
|
$39.6M |
Sector Composition
| 1 | Technology | 17.95% |
| 2 | Financials | 15.77% |
| 3 | Healthcare | 13.34% |
| 4 | Consumer Discretionary | 10.43% |
| 5 | Industrials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SWN
1476
DELISTED
Southwestern Energy Company
SWN
| $164K | ﹤0.01% | +35,000 | New | +$164K |
|
1477
Ardelyx
ARDX
$1.53B
| $163K | ﹤0.01% | 58,200 +13,300 | +30% | +$37.2K |
|
|
QIWI
1478
DELISTED
QIWI PLC
QIWI
| $160K | ﹤0.01% | 11,145 | – | – |
|
1479
Synlogic
SYBX
$17M
| $159K | ﹤0.01% | 20,900 +4,800 | +30% | +$36.5K |
|
1480
Lineage Cell Therapeutics
LCTX
$267M
| $157K | ﹤0.01% | 119,900 +27,500 | +30% | +$36K |
|
1481
Replimune Group
REPL
$422M
| $154K | ﹤0.01% | +10,100 | New | +$154K |
|
|
VIVS
1482
VivoSim Labs, Inc. Common Stock
VIVS
$6.34M
| $151K | ﹤0.01% | 152,400 +34,800 | +30% | +$34.5K |
|
|
EVLO
1483
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $151K | ﹤0.01% | +18,900 | New | +$151K |
|
|
PTE
1484
DELISTED
PolarityTE, Inc. Common Stock
PTE
| $147K | ﹤0.01% | 13,700 +3,200 | +30% | +$34.3K |
|
1485
Spero Therapeutics
SPRO
$116M
| $143K | ﹤0.01% | +11,200 | New | +$143K |
|
|
DOVA
1486
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $141K | ﹤0.01% | 15,900 +3,600 | +29% | +$31.9K |
|
1487
GrafTech
EAF
$255M
| $139K | ﹤0.01% | 10,880 -570 | -5% | -$7.28K |
|
|
SCTL
1488
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $139K | ﹤0.01% | 23,700 +5,400 | +30% | +$31.7K |
|
1489
DURECT Corp
DRRX
$59.6M
| $134K | ﹤0.01% | 214,000 +49,000 | +30% | +$30.7K |
|
|
WFT
1490
DELISTED
Weatherford International plc
WFT
| $134K | ﹤0.01% | 191,768 | – | – |
|
|
TBIO
1491
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $132K | ﹤0.01% | 13,000 +2,900 | +29% | +$29.4K |
|
1492
Gyre Therapeutics
GYRE
$703M
| $131K | ﹤0.01% | 16,100 +3,600 | +29% | +$29.3K |
|
|
JNCE
1493
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $131K | ﹤0.01% | 21,100 +4,800 | +29% | +$29.8K |
|
1494
KALA BIO
KALA
$78.8M
| $129K | ﹤0.01% | 15,600 +3,600 | +30% | +$29.8K |
|
1495
ADT
ADT
$7.14B
| $127K | ﹤0.01% | 19,861 -720 | -3% | -$4.6K |
|
|
CMRX
1496
DELISTED
Chimerix, Inc.
CMRX
| $126K | ﹤0.01% | 59,900 +13,700 | +30% | +$28.8K |
|
1497
RPC Inc
RES
$1.05B
| $125K | ﹤0.01% | 10,966 | – | – |
|
1498
Cogent Biosciences
COGT
$1.69B
| $114K | ﹤0.01% | +25,900 | New | +$114K |
|
|
AVEO
1499
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $114K | ﹤0.01% | 138,900 +31,700 | +30% | +$26K |
|
1500
Larimar Therapeutics
LRMR
$310M
| $113K | ﹤0.01% | 41,100 +9,400 | +30% | +$25.8K |
|